View Archive »
About The Cover
hMENA11a defines an epithelial phenotype and is expressed alternatively to hMENAΔv6 isoform in lung cancer cell lines. See Bria et al.
|
|
Table of Contents
Editorial
|
| Tetraploidy and tumor development |
|
https://doi.org/10.18632/oncotarget.2790
|
| 10959-10960 |
|
| Angiostatic vaccines an underestimated approach of cancer therapy |
|
https://doi.org/10.18632/oncotarget.2791
|
| 10961-10962 |
|
| ADAM10 and ADAM17: New Players in Trastuzumab Resistance |
|
https://doi.org/10.18632/oncotarget.2794
|
| 10963-10964 |
|
| Reciprocity in breast cancer progression |
|
https://doi.org/10.18632/oncotarget.2853
|
| 10967-10968 |
Reviews
|
| Critical role of NFκB in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2624
|
| 10969-10975 |
|
| A pathophysiological view of the long noncoding RNA world |
|
https://doi.org/10.18632/oncotarget.2770
|
| 10976-10996 |
Research Perspectives
|
| Oncotargeting G proteins: The Hippo in the room |
|
https://doi.org/10.18632/oncotarget.2815
|
| 10997-10999 |
|
| Wnt signaling de novo lipogenesis adipogenesis and ectopic fat |
|
https://doi.org/10.18632/oncotarget.2769
|
| 11000-11003 |
|
| Bioinformatics analysis of the serine and glycine pathway in cancer cells |
|
https://doi.org/10.18632/oncotarget.2668
|
| 11004-11013 |
|
| Revealed: The spy who regulates neuroblastoma stem cells |
|
https://doi.org/10.18632/oncotarget.2839
|
| 11014-11016 |
Priority Research Papers
|
| Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFRpathway proteins in colorectal cancer tissue |
|
https://doi.org/10.18632/oncotarget.2669
|
| 11017-11028 |
|
| Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition |
|
https://doi.org/10.18632/oncotarget.2789
|
| 11029-11037 |
|
| Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2701
|
| 11038-11053 |
|
| Prognostic impact of alternative splicingderived hMENA isoforms in resected nodenegative nonsmallcell lung cancer |
|
https://doi.org/10.18632/oncotarget.2609
|
| 11054-11063 |
Clinical Research Papers
|
| IP10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival |
|
https://doi.org/10.18632/oncotarget.2519
|
| 11064-11080 |
|
| NBN gain is predictive for adverse outcome following imageguided radiotherapy for localized prostate cancer |
|
https://doi.org/10.18632/oncotarget.2404
|
| 11081-11090 |
|
| Development and prospective multicenter evaluation of the long noncoding RNA MALAT1 as a diagnostic urinary biomarker for prostate cancer |
|
https://doi.org/10.18632/oncotarget.2691
|
| 11091-11102 |
|
| Clinical significance and therapeutic value of glutathione peroxidase 3 GPx3 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2549
|
| 11103-11120 |
|
| Peritumoral Neuropilin1 and VEGF receptor2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy |
|
https://doi.org/10.18632/oncotarget.2553
|
| 11121-11132 |
|
| The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal |
|
https://doi.org/10.18632/oncotarget.2563
|
| 11133-11142 |
|
| Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a noncontrolled clinical trial |
|
https://doi.org/10.18632/oncotarget.2603
|
| 11143-11153 |
|
| A phase 1b openlabel study of trebananib plus bevacizumab or motesanib in patients with solid tumours |
|
https://doi.org/10.18632/oncotarget.2568
|
| 11154-11167 |
|
| Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience |
|
https://doi.org/10.18632/oncotarget.2584
|
| 11168-11179 |
Research Papers
|
| Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular crosstalk with Schwann cells |
|
https://doi.org/10.18632/oncotarget.2611
|
| 11180-11192 |
|
| The IGF1 receptor inhibitor picropodophyllin potentiates the antimyeloma activity of a BH3mimetic |
|
https://doi.org/10.18632/oncotarget.1933
|
| 11193-11208 |
|
| Inhibition of Lon blocks cell proliferation enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer |
|
https://doi.org/10.18632/oncotarget.2026
|
| 11209-11224 |
|
| Maspin expression in prostate tumor elicits host antitumor immunity |
|
https://doi.org/10.18632/oncotarget.2615
|
| 11225-11236 |
|
| Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells |
|
https://doi.org/10.18632/oncotarget.2616
|
| 11237-11251 |
|
| Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells via inhibition of CLIC1mediated ion current |
|
https://doi.org/10.18632/oncotarget.2617
|
| 11252-11268 |
|
| Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression |
|
https://doi.org/10.18632/oncotarget.2579
|
| 11269-11282 |
|
| Multiple myeloma cells recruit tumorsupportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype |
|
https://doi.org/10.18632/oncotarget.2207
|
| 11283-11296 |
|
| DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.2315
|
| 11297-11307 |
|
| Therapeutic potential of ERK5 targeting in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.2324
|
| 11308-11318 |
|
| EZH2 promotes angiogenesis through inhibition of miR1/Endothelin1 axis in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.2435
|
| 11319-11332 |
|
| Overexpression of human βdefensin 2 promotes growth and invasion during esophageal carcinogenesis |
|
https://doi.org/10.18632/oncotarget.2416
|
| 11333-11344 |
|
| Interactome analysis of myeloidderived suppressor cells in murine models of colon and breast cancer |
|
https://doi.org/10.18632/oncotarget.2489
|
| 11345-11353 |
|
| Identification and validation of p50 as the cellular target of eriocalyxin B |
|
https://doi.org/10.18632/oncotarget.2461
|
| 11354-11364 |
|
| Targeting of mutant p53induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells |
|
https://doi.org/10.18632/oncotarget.2497
|
| 11365-11380 |
|
| Human PIF1 helicase supports DNA replication and cell growth under oncogenicstress |
|
https://doi.org/10.18632/oncotarget.2501
|
| 11381-11398 |
|
| Bcl2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase9 inhibition |
|
https://doi.org/10.18632/oncotarget.2550
|
| 11399-11412 |
|
| Chemopreventive apigenin controls UVBinduced cutaneous proliferation and angiogenesis through HuR and thrombospondin1 |
|
https://doi.org/10.18632/oncotarget.2551
|
| 11413-11427 |
|
| Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms tumor suppressive function and therapeutic relevance |
|
https://doi.org/10.18632/oncotarget.2552
|
| 11428-11441 |
|
| Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils |
|
https://doi.org/10.18632/oncotarget.2556
|
| 11442-11451 |
|
| Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2576
|
| 11452-11463 |
|
| Human recombinant truncated RNASET2 devoid of RNase activity; A potential cancer therapeutic agent |
|
https://doi.org/10.18632/oncotarget.2562
|
| 11464-11478 |
|
| Mastl kinase a promising therapeutic target promotes cancer recurrence |
|
https://doi.org/10.18632/oncotarget.2565
|
| 11479-11489 |
|
| CXCL12/CXCR4 signaling counteracts docetaxelinduced microtubule stabilization via p21activated kinase 4dependent activation of LIM domain kinase 1 |
|
https://doi.org/10.18632/oncotarget.2571
|
| 11490-11500 |
|
| Imagebased RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support |
|
https://doi.org/10.18632/oncotarget.2572
|
| 11501-11512 |
|
| STAT3 inhibition suppresses proliferation of retinoblastoma through downregulation of positive feedback loop of STAT3/miR1792 clusters |
|
https://doi.org/10.18632/oncotarget.2546
|
| 11513-11525 |
|
| A novel DAGdependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression |
|
https://doi.org/10.18632/oncotarget.2578
|
| 11526-11540 |
|
| Inhibition of glioblastoma malignancy by Lgl1 |
|
https://doi.org/10.18632/oncotarget.2580
|
| 11541-11551 |
|
| Methylation of miR1295p CpG island modulates multidrug resistance in gastric cancer by targeting ABC transporters |
|
https://doi.org/10.18632/oncotarget.2594
|
| 11552-11563 |
|
| High Id1 expression a generally negative prognostic factor paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients |
|
https://doi.org/10.18632/oncotarget.2595
|
| 11564-11575 |
|
| Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway |
|
https://doi.org/10.18632/oncotarget.2596
|
| 11576-11587 |
|
| AMACR amplification and overexpression in primary imatinibnaïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis |
|
https://doi.org/10.18632/oncotarget.2597
|
| 11588-11603 |
|
| RYBP expression is associated with better survival of patients with hepatocellular carcinoma HCC and responsiveness to chemotherapy of HCC cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.2598
|
| 11604-11619 |
|
| Activation of miR9 by human papillomavirus in cervical cancer |
|
https://doi.org/10.18632/oncotarget.2599
|
| 11620-11630 |
|
| Downregulation of miR203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK |
|
https://doi.org/10.18632/oncotarget.2600
|
| 11631-11640 |
|
| Cisplatin in combination with Phenethyl Isothiocyanate PEITC a potential new therapeutic strategy for malignant pleural mesothelioma |
|
https://doi.org/10.18632/oncotarget.2604
|
| 11641-11652 |
|
| Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL2 |
|
https://doi.org/10.18632/oncotarget.2605
|
| 11653-11668 |
|
| MicroRNA9 promotes tumor metastasis via repressing Ecadherin in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2581
|
| 11669-11680 |
|
| Suppressor of fused Sufu represses Gli1 transcription and nuclear accumulation inhibits glioma cell proliferation invasion and vasculogenic mimicry improving glioma chemosensitivity and prognosis |
|
https://doi.org/10.18632/oncotarget.2585
|
| 11681-11694 |
|
| Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer |
|
https://doi.org/10.18632/oncotarget.2586
|
| 11695-11708 |
|
| Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma |
|
https://doi.org/10.18632/oncotarget.2606
|
| 11709-11722 |
|
| MTOR inhibition enhances NVPAUY922induced autophagymediated KIT degradation and cytotoxicity in imatinibresistant gastrointestinal stromal tumors |
|
https://doi.org/10.18632/oncotarget.2607
|
| 11723-11736 |
|
| Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5FU and LOHP |
|
https://doi.org/10.18632/oncotarget.2591
|
| 11737-11751 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
